Washington · statute · Wash. Rev. Code ch. 70.225 · 12 active provisions
The definitions in this section apply throughout this chapter unless the context clearly requires otherwise.(1) "Controlled substance" has the meaning provided in RCW 69.50.101.(2) "Department" means the department of health.(3) "Patient" means the person or animal who is the ultimate user of a drug for whom a prescrip…
(1) The department shall establish and maintain a prescription monitoring program to monitor the prescribing and dispensing of all Schedules II, III, IV, and V controlled substances and any additional drugs identified by the pharmacy quality assurance commission as demonstrating a potential for abuse by all professiona…
The department shall adopt rules to implement this chapter.
To the extent that funding is provided for such purpose through federal or private grants, or is appropriated by the legislature, the health care authority shall study the feasibility of enhancing the prescription monitoring program established in RCW 70.225.020 in order to improve the quality of state purchased health…
(1) All information submitted to the prescription monitoring program is confidential, exempt from public inspection, copying, and disclosure under chapter 42.56 RCW, not subject to subpoena or discovery in any civil action, and protected under federal health care information privacy requirements, except as provided in…
Beginning November 15, 2017, the department shall annually report to the governor and the appropriate committees of the legislature on the number of facilities, entities, or provider groups identified in *RCW 70.225.040(3) (l) and (m) that have integrated their federally certified electronic health records with the pre…
The department may contract with another agency of this state or with a private vendor, as necessary, to ensure the effective operation of the prescription monitoring program. Any contractor is bound to comply with the provisions regarding confidentiality of prescription information in RCW 70.225.040 and is subject to…
(1) A dispenser who knowingly fails to submit prescription monitoring information to the department as required by this chapter or knowingly submits incorrect prescription information is subject to disciplinary action under chapter 18.130 RCW.(2) A person authorized to have prescription monitoring information under thi…
(1) Test sites that may receive access to data in the prescription monitoring program under RCW 70.225.040 must be:(a) Licensed by the department as a test site under chapter 70.42 RCW; and(b) Certified as a drug testing laboratory by the United States department of health and human services, substance abuse and mental…
(1) Access to data in the qualifying laboratory must be under the supervision of the responsible person as designated by the United States department of health and human services, substance abuse and mental health services administration certification program.(2) Such data cannot be gathered, shared, sold, or used in a…
(1) In order to expand integration of prescription monitoring program data into certified electronic health record technologies, the department must collaborate with health professional and facility associations, vendors, and others to:(a) Conduct an assessment of the current status of integration;(b) Provide recommend…
See note following RCW 7.70.060.